Publicacións en colaboración con investigadores/as de Howard Hughes Medical Institute (2)

2024

  1. GLABRA2 transcription factor integrates arsenic tolerance with epidermal cell fate determination

    New Phytologist

2014

  1. Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia

    Clinical Cancer Research, Vol. 20, Núm. 8, pp. 2092-2103